Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-006328

SVP and General Counsel sold 18,878 shares at an average $8.59 ($162,186)

  • SVP and General Counsel acquired 85,697 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-06 Grant or award : show line 1 in the form +85,697 158,556 D
2023-03-06 Sale : show line 2 in the form −5,491 $8.57 $47,058 153,065 D
2023-03-07 Sale : show line 3 in the form −13,387 $8.60 $115,128 139,678 D
Open-market sales · 18,878 sh · avg $8.59 · $162,186

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-06 Grant or award : show line 4 in the form Stock Option (right to buy) +128,599 128,599 D
Loading xslF345X03/form4.xml…